MedPath

GADOVIST 1.0

GADOVIST 1.0

Approved
DIN Number

02241089

Drug Class

Human

Market Date

Jan 30, 2004

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241089
AIG Number0138761002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA09 GADOBUTROL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

GADOBUTROLActive
Strength: 604.72 MG / ML
Monograph: GADOBUTROL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.